FDA Seeks Public Input on Draft Guidance Relating to Impacts of the Use of Certain Animal Drugs on Human Health

The Food and Drug Administration (FDA) announced the availability of a draft guidance for industry #152 entitled “Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern.” This draft guidance informs stakeholders about FDA's current method for evaluating potential effects of antimicrobial new animal drugs on human health as part of the new animal drug application process. FDA will accept public comments through March 20, 2023.